Glycoprotein IIb/IIIa receptor antagonists in acute myocardial infarction and primary coronary stenting: Not always effective

S. Banai, A. Medina, A. Keren

Research output: Contribution to journalArticlepeer-review

Abstract

Glycoprotein IIb/IIIa antagonists have been shown to be effective in reducing thrombotic complications prior to high-risk coronary interventions. Some studies have reported improved coronary flow after abciximab in slow or no-reflow phenomenon. We report a case in which abciximab did not clear the thrombotic occlusion or restore artery flow. Further studies are needed into the refractory no-flow phenomenon.

Original languageEnglish
Pages (from-to)241-243
Number of pages3
JournalInternational Journal of Cardiovascular Interventions
Volume3
Issue number4
DOIs
StatePublished - 2000
Externally publishedYes

Keywords

  • Abciximab acute MI
  • No-reflow phenomenon
  • Primary angioplasty

Fingerprint

Dive into the research topics of 'Glycoprotein IIb/IIIa receptor antagonists in acute myocardial infarction and primary coronary stenting: Not always effective'. Together they form a unique fingerprint.

Cite this